Thomas Unger
Universiteit Maastricht
H-index: 115
Europe-Netherlands
Top articles of Thomas Unger
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling | Elena Kaschina Dilyara Lauer Christoph Lange Thomas Unger | 2024/2/17 | |
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors | British journal of pharmacology | Stephen PH Alexander Arthur Christopoulos Anthony P Davenport Eamonn Kelly Alistair A Mathie | 2023/10 |
S-12-7: THE RENIN ANGIOTENSIN SYSTEM IN BASIC AND CLINICAL RESEARCH | Journal of Hypertension | Thomas Unger | 2023/1/1 |
The (Pro) renin Receptor-A Regulatory Nodal Point in Disease Networks | Heiko Funke-Kaiser Thomas Unger | 2023/10/1 | |
Unikernel Linux (UKL) | Ali Raza Thomas Unger Matthew Boyd Eric B Munson Parul Sohal | 2023/5/8 | |
Angiotensin receptors in GtoPdb v. 2023.1 | IUPHAR/BPS Guide to Pharmacology CITE | Wayne Alexander Kenneth E Bernstein Kevin J Catt Marc De Gasparo Khuraijam Dhanachandra Singh | 2023/4/26 |
The (pro) renin receptor as a pharmacological target in cardiorenal diseases | Heiko Funke-Kaiser Thomas Unger | 2023/11 | |
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension | Aletta E Schutte Tazeen H Jafar Neil R Poulter Albertino Damasceno Nadia A Khan | 2023/2/1 | |
Angiotensin AT2 receptor stimulation alleviates collagen-induced arthritis by upregulation of regulatory T cell numbers | Frontiers in Immunology | Bettina Sehnert Veronica Valero-Esquitino Georg Schett Thomas Unger Ulrike Muscha Steckelings | 2022/7/8 |
Integrating Unikernel Optimizations in a General Purpose OS | arXiv preprint arXiv:2206.00789 | Ali Raza Thomas Unger Matthew Boyd Eric Munson Parul Sohal | 2022/6/1 |
Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes | Biomedicines | Bettina Greiner Manuela Sommerfeld Ulrich Kintscher Thomas Unger Kai Kappert | 2022/12/16 |
The angiotensin AT2 receptor: from a binding site to a novel therapeutic target | U Muscha Steckelings Robert E Widdop Edward D Sturrock Lizelle Lubbe Tahir Hussain | 2022/10/1 | |
Renin‐angiotensin system inhibitors in patients with COVID‐19: a meta‐analysis of randomized controlled trials led by the international society of hypertension | Sonali R Gnanenthiran Claudio Borghi Dylan Burger Bruno Caramelli Fadi Charchar | 2022/9/6 | |
May Measurement Month: results of 12 national blood pressure screening programmes between 2017 and 2019 | European Heart Journal Supplements | Neil R Poulter Claudio Borghi Albertino Damasceno Tazeen H Jafar Nadia A Khan | 2022/9/1 |
May Measurement Month 2019: results of blood pressure screening from 47 countries | European heart journal supplements | Neil R Poulter Claudio Borghi Albertino Damasceno Tazeen H Jafar Nadia Khan | 2021/5/1 |
AT2R stimulation with C21 prevents arterial stiffening and endothelial dysfunction in the abdominal aorta from mice fed a high-fat diet | Clinical Science | Raquel González-Blázquez Martín Alcalá José Miguel Cárdenas-Rebollo Marta Viana Ulrike Muscha Steckelings | 2021/12 |
C21 preserves endothelial function in the thoracic aorta from DIO mice: role for AT2, Mas and B2 receptors | Clinical science | Raquel González-Blázquez Martín Alcalá María S Fernández-Alfonso Ulrike Muscha Steckelings M Paz Lorenzo | 2021/5 |
Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial | JAMA neurology | Rustam Al-Shahi Salman Martin S Dennis Peter AG Sandercock Cathie LM Sudlow Joanna M Wardlaw | 2021/10/1 |
COMPOUND 21 IMPROVES VASCULAR FUNTION IN THE THORACIC AORTA FROM OBESE MICE: IMPLICATION OF AT2, MAS AND B2 RECEPTORS | Journal of Hypertension | Raquel González-Blázquez Marta Gil-Ortega Martín Alcalá Marta Viana Thomas Unger | 2021/4/1 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | Lancet (London, England) | RECOVERY Collaborative Group | 2021/2/13 |
